Ricin Toxoid for Prophylactic Vaccine Trials from Canada
Detoxified ricin toxoid used in phase I/II vaccine trials for inducing immunity against ricin exposure. Fits HTS 3002.49.0010 as a toxin for prophylactic uses in clinical settings. Developed for military and civilian biodefense.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Submit IND application details and trial protocol to justify prophylactic classification
• Use validated cold chain with data loggers; pitfall is thermal excursion claims denial
• Declare as 'clinical trial toxin' to differentiate from research grade